Kawasumi Laboratories, Incorporated Announces Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2017 and Full Year Ending March 31, 2018; Announces Dividend for the Year Ended March 31, 2017, Payable on June 23, 2017; Provides Dividend Guidance for the Second Quarter of Fiscal 2018 and for the Year Ending March 31, 2018
The company provided consolidated earnings guidance for the six months ending September 30, 2017 and full year ending March 31, 2018. For the six months, the company expects net sales of ¥12,300 million, operating profit of ¥100 million, ordinary profit of ¥150 million and profit attributable to owners of parent of ¥150 million or ¥6.88 per share.
For the full year ending March 31, 2018, the company expects net sales of ¥25,000 million, operating profit of ¥600 million, ordinary profit of ¥650 million and profit attributable to owners of parent of ¥600 million or ¥27.50 per share.
The company announced dividend of ¥10.00 per share for the year ended March 31, 2017 against ¥7.50 per share paid for the same period a year ago. The dividend is payable on June 23, 2017.
The company provided dividend guidance for the second quarter of fiscal 2018 and for the year ending March 31, 2018. For the second quarter of fiscal 2018, the company expects to pay dividend of ¥7.50 per share against a paid dividend of ¥7.50 per share for the same period a year ago.
For the year ending March 31, 2018, the company expects to pay dividend of ¥7.50 per share against ¥10.00 per share announced for the same period a year ago.